Matches in Nanopublications for { ?s ?p "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP285880.RAieexXC0OLMA0ASjwEQIZPsGYwwDgMT4RqMrXtBs61II130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285880.RAieexXC0OLMA0ASjwEQIZPsGYwwDgMT4RqMrXtBs61II130_provenance.
- NP291746.RAqlR5Oz1qu344y_Pf0w1JI10YOddUc8rvkaqWuUiIz58130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291746.RAqlR5Oz1qu344y_Pf0w1JI10YOddUc8rvkaqWuUiIz58130_provenance.
- NP923742.RA1QF9JrtOcuZeImjxz4KnBKF2ybVvh2VC6cPSlRKHdeM130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923742.RA1QF9JrtOcuZeImjxz4KnBKF2ybVvh2VC6cPSlRKHdeM130_provenance.
- NP858560.RAUZnGsBvYww8VL5wjCKZJJVmUSL_G5OARBYMZalVsGrU130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858560.RAUZnGsBvYww8VL5wjCKZJJVmUSL_G5OARBYMZalVsGrU130_provenance.
- assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP924923.RAZWrqe3oIsYByxt0PL9dkIFQdUX0qu4LUVr_c3zcJLX4130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924923.RAZWrqe3oIsYByxt0PL9dkIFQdUX0qu4LUVr_c3zcJLX4130_provenance.
- NP790284.RAHTjsErVPryXA8wvQtSk-Fp6zud_q3453usmLv1H2xeM130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790284.RAHTjsErVPryXA8wvQtSk-Fp6zud_q3453usmLv1H2xeM130_provenance.
- NP924922.RAMwazKF6IlwCTLIEzxvO1AeCZ_wBDIwCF0h6vpry7CNE130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924922.RAMwazKF6IlwCTLIEzxvO1AeCZ_wBDIwCF0h6vpry7CNE130_provenance.
- NP858696.RA8UuUMSPTO5EcfiWJvZw37-b00DjxFsWEzhgVNT-Lz-8130_assertion description "[Our results indicate that inhibition of NF-?B in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858696.RA8UuUMSPTO5EcfiWJvZw37-b00DjxFsWEzhgVNT-Lz-8130_provenance.